DigiTx Partners is a venture capital firm launched in 2016 as a joint venture between Astellas Pharma and MPM Capital, investing in early-stage digital health companies leveraging data-driven technology to improve patient outcomes. The firm raised $75 million for its Rx Digital Fund in 2018.
50% of their portfolio is in Healthcare. They made 1 investments in the last 12 months. Average disclosed round size is $13.5M (across 18 rounds with reported amounts).
Portfolio
16
Fund Size
$75M
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
18 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Auxira Health | Seed | $7.8M | Dec 2025 |
 Neon Health | Unknown | $6M | Jan 2025 |
 Eko Health | Series C | $41M | Jun 2024 |
 CardioSignal | Series A | $10M | Jan 2024 |
 CardioSignal | Series A | $10M | Jan 2024 |
 Mightier | Series B | $17M | Dec 2021 |
| CCleerly Coronary | Series B | $43M | Jun 2021 |
 G-Tech Medical | Series A | $6.7M | Jun 2020 |
| EEko | Series B | $20M | Sep 2019 |
 NeoSensory | Series A | $10M | Jan 2019 |
 Tissue Analytics | Series A | $5M | Jan 2018 |
| SSavonix | Seed | $1.5M | Dec 2015 |
 Embr Labs | Series B | $35M | — |
 Ciba Health | Series A | $10M | — |
 Siris Medical | Unknown | $4M | — |
| Tissue Analytics | Seed | $1.9M | — |
| SSavonix | Series A | $9.6M | — |
 StrokeDx | Seed | $5M | — |
Top Co-Investors
PBJ Capital2 shared
NTTVC2 shared
AARP2 shared
Sandwater2 shared
Maki.vc2 shared
Rethink Impact2 shared
Wavemaker Partners2 shared
Tao Capital Partners1 shared
True Ventures1 shared
Sony Innovation Fund by IGV1 shared
M Ventures1 shared
XTX Markets1 shared
Mayo Clinic Ventures1 shared
Martin Ventures1 shared
Seraph Group1 shared
New Leaf Venture Partners1 shared
LRVHealth1 shared
The Cigna Group Ventures1 shared
Vensana Capital1 shared
EDBI1 shared
Last updated: 8 September 2026